GJA1 and atrial fibrillation: A more direct approach to modifying intercellular coupling is the overexpression of gap junction proteins via gene therapy; increased Cx43 expression has been shown to improve conduction velocity and reduce atrial fibrillation susceptibility (Igarashi et al., 2012).